Drugs / G238
last change Nov 2014 re-read 2 minutes ago

G238

Developed for
otomycosis
Investigated by
Salvat

Trials 1 · a red edge is where a trial was stopped

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01993823 May 2013 → Nov 2014 otomycosis Salvat Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as G238 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01993823
Route Other “Five drops into the ear canal twice daily for 14 days” NCT01993823